Clinical Trial Update: R-ACVBP Versus R-CHOP in Patients Aged 60-65 With Diffuse Large B-cell Lymphoma [Phase 3]

View source ↗

Summary

Phase 3 trial comparing R-ACVBP to R-CHOP in older adults with diffuse large B-cell lymphoma has terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• R-ACVBP
• R-CHOP

Snippet

Sponsor: Lymphoma Study Association | Conditions: Lymphoma, Large-Cell, Diffuse | Phase 3 | Status: TERMINATED